Inventor
ZIEGLER IRIS
DE17 patents
⚠️ This page may combine multiple inventors who share the name “ZIEGLER IRIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GRUENENTHAL GMBH
13 patentsUS6576260B2Jun 10, 2003
Sustained-release form of administration containing tramadol saccharinate
GRUENENTHAL GMBH53 citations96
US6558701B2May 6, 2003
Multilayer tablet for administering a fixed combination of tramadol and diclofenac
GRUENENTHAL GMBH59 citations96
US8383152B2Feb 26, 2013
Pharmaceutical dosage form
GRUENENTHAL GMBH78 citations93
US7906141B2Mar 15, 2011
Sustained-release, oral pharmaceutical forms of formulation
GRUENENTHAL GMBH28 citations92
US6558704B1May 6, 2003
Process for preparing pellets containing up to 90 wt.% of a pharmaceutical active ingredient
GRUENENTHAL GMBH41 citations90
US6451350B1Sep 17, 2002
Controlled release tramadol preparation with a storage-stable release profile and process for their production
GRUENENTHAL GMBH25 citations90
US9750701B2Sep 5, 2017
Pharmaceutical dosage form
GRUENENTHAL GMBH17 citations88
US7897173B2Mar 1, 2011
Sustained-release, oral pharmaceutical formulations and methods of making and using same
GRUENENTHAL GMBH14 citations84
US7572463B2Aug 11, 2009
Oral dosage forms
GRUENENTHAL GMBH9 citations84
US8361506B2Jan 29, 2013
Fast release dosage forms for antibiotics
GRUENENTHAL GMBH3 citations58
US11007156B2May 18, 2021
Prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol
GRUENENTHAL GMBH0 citations52
US7410965B2Aug 12, 2008
Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol
GRUENENTHAL GMBH1 citations52
US7666860B2Feb 23, 2010
Melt-formulated, multi-particulate oral dosage form
GRUENENTHAL GMBH1 citations51